GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Short Percentage of Float

BetterLife Pharma (STU:NPAU) Short Percentage of Float


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of BetterLife Pharma's Short Percentage of Float

For the Biotechnology subindustry, BetterLife Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Short Percentage of Float falls into.


BetterLife Pharma (STU:NPAU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Short Percentage of Float
Comparable Companies
TSXV:XRTX XCNQ:TRYP XCNQ:CHGX TSXV:HEM XCNQ:DRUG TSXV:RKV TSXV:RP TSX:APLI XCNQ:MESC XCNQ:GLOW OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BETRF:USA NPAU:Germany BETR:Canada
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
Website
https://www.abetterlifepharma.com
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines